Federated Hermes’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.19M | Buy |
1,667,338
+417,157
| +33% | +$1.55M | 0.01% | 670 |
|
|
2025
Q1 | $4.04M | Buy |
1,250,181
+1,246,419
| +33,132% | +$4.03M | 0.01% | 761 |
|
|
2024
Q4 | $21K | Buy |
+3,762
| New | +$21K | ﹤0.01% | 1765 |
|
|
2024
Q2 | – | Sell |
-27
| Closed | -$860 | – | 2054 |
|
|
2024
Q1 | $860 | Buy |
+27
| New | +$860 | ﹤0.01% | 1965 |
|
|
2022
Q3 | – | Sell |
-219
| Closed | -$2K | – | 2171 |
|
|
2022
Q2 | $2K | Buy |
+219
| New | +$2K | ﹤0.01% | 1975 |
|
|
2021
Q3 | – | Sell |
-4,200
| Closed | -$101K | – | 2250 |
|
|
2021
Q2 | $101K | Sell |
4,200
-145,800
| -97% | -$3.51M | ﹤0.01% | 1788 |
|
|
2021
Q1 | $6.51M | Hold |
150,000
| – | – | 0.01% | 774 |
|
|
2020
Q4 | $6.22M | Buy |
+150,000
| New | +$6.22M | 0.01% | 750 |
|